Skip to main content
    R

    Regeneron Pharmaceuticals Inc (REGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $957.76
    +5.36 (+0.56%)

    Market Cap: $98.84B

    Last updated: Nov 17, 2026 at 4:34 PM ET

    Regeneron Pharmaceuticals Inc (REGN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Regeneron Pharmaceuticals (REGN) has a latest price of $957.76 on Nov 17, 2026, 3.4% below its 52-week high of $991.73. Its price rose 38.4% over the past 12 months. The month-end price rose 168.9% over the 10 years through Oct 2026, a compound annual rate of 10.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $1,184.69 in Aug 2024 and its lowest $277.40 in Sep 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart REGN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for REGN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 13.9%, and over 6 months it rose 52.3%. The month-end price rose 19.0% over the 3 years through Oct 2026, a compound annual rate of 6.0%.

    PeriodChange
    1 month+22.5%
    3 months+13.9%
    6 months+52.3%
    12 months+38.4%
    12 months, with dividends+39.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+19.0%+6.0%
    5 years+45.0%+7.7%
    10 years+168.9%+10.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 30.7%, and its weakest was 2024, when it fell 18.9%.

    YearCloseChange
    2026 through Oct 2026$927.89+20.2%
    2025$771.87+8.4%
    2024$712.33-18.9%
    2023$878.29+21.7%
    2022$721.49+14.2%
    2021$631.52+30.7%
    2020$483.11+28.7%
    2019$375.48+0.5%
    2018$373.50-0.7%
    2017$375.96+2.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 16.6% above its 50-day average of $821.61 and 28.0% above its 200-day average of $748.12.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$957.76
    52-week high$991.73-3.4%
    52-week low$590.83+62.1%
    50-day average$821.61+16.6%
    200-day average$748.12+28.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 59.7%.

    MeasureValue
    1-year beta0.38
    Largest fall, 1 year-25.9%
    Largest fall, 3 years-59.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Regeneron Pharmaceuticals traded at 17.4x earnings at the end of 2025, against a 5-year median of 16.4x and a 10-year median of 16.9x.

    REGN valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About REGN

    What is REGN's 1-year price change?

    Regeneron Pharmaceuticals's price rose 38.4% over the past 12 months. With dividends included, the 12-month total return was 39.0%.

    What is REGN's 5-year price change?

    Regeneron Pharmaceuticals's month-end price rose 45.0% over the 5 years through Oct 2026, a compound annual rate of 7.7%. These figures leave out dividends.

    What is REGN's 52-week high and low?

    Regeneron Pharmaceuticals's 52-week high is $991.73 and its 52-week low is $590.83. Its latest price of $957.76 on Nov 17, 2026 is 3.4% below the high.

    What is REGN's beta?

    Regeneron Pharmaceuticals's 1-year beta against the S&P 500 is 0.38, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 25.9%.

    Is the REGN chart free?

    Yes. Advanced Charting for REGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.